BI 764532
Boehringer Ingelheim
['sclc']
8: overall, bi 764532 showed clinically manageable tolerability, and mtd has not been reached at the doses administered to date. it showed promising efficacy not only in sclc but also in nec and lcnec. #cancerresearch #asco23 
🫁Pneumo-Onco🩺 Chef de Pôle de Méd à Orientation Onco 🏥 @CHToulonLaSeyne 🔬Conseil Scientifique @IFCTLung / Pdte du 3C VarOuest 👉🏼#HopitalPublic #LungCancer